A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma.

Lv, Chao

A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma. [electronic resource] - World journal of surgical oncology Apr 2013 - 96 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1477-7819

10.1186/1477-7819-11-96 doi


Adenocarcinoma--drug therapy
Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--genetics
Carcinoma, Non-Small-Cell Lung--drug therapy
Cisplatin--administration & dosage
Crown Ethers--administration & dosage
DNA-Binding Proteins--genetics
Deoxycytidine--administration & dosage
Endonucleases--genetics
Female
Follow-Up Studies
Humans
Induction Chemotherapy
Lung Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Staging
Pilot Projects
Prognosis
Quinazolines--administration & dosage
RNA, Messenger--genetics
Real-Time Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction
Ribonucleoside Diphosphate Reductase
Tumor Suppressor Proteins--genetics
Gemcitabine